Citric Acid

Citric Acid

SCHEMBL1231114

O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Pd+2].[Pd+2].[Pd+2]

nearest known ligand 0.89

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BHRH2IMPA1

The experimentally established mechanism targets of Citric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CA4 P22748 3/20 0.89
▸ ALDH1A1 P00352 1/20 0.33
▸ CASP1 P29466 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Citric Acid SCHEMBL17500032 1.00 CA4 (0.89) CA4ALDH1A1CASP1
Citric Acid SCHEMBL10699295 0.97 CA4 (0.84) CA4ALDH1A1CASP1
Citric Acid SCHEMBL29587574 0.97 CA4 (0.94) CA4ALDH1A1CASP1
Citric Acid SCHEMBL22686437 0.97 CA4 (0.94) CA4ALDH1A1CASP1
Citric Acid SCHEMBL42945 0.97 CA4 (0.94) CA4ALDH1A1CASP1
Citric Acid SCHEMBL1291555 0.97 CA4 (0.94) CA4ALDH1A1CASP1
Citric Acid SCHEMBL23012792 0.94 CA4 (0.89) CA4ALDH1A1CASP1
Citric Acid SCHEMBL20668544 0.94 CA4 (0.89) CA4ALDH1A1CASP1
Citric Acid SCHEMBL2235356 0.94 CA4 (1.00) CA4ALDH1A1CASP1
Citric Acid SCHEMBL20668547 0.94 CA4 (0.89) CA4ALDH1A1CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025082175-A1 EGGSHELL-TYPE CATALYST, MODIFIED CARRIER, AND PREPARATION METHOD THEREFOR AND USE THEREOF 中国石油化工股份有限公司 2025-04-24 — — WO claimed
CN-119857480-A Ultrathin eggshell type high-dispersion catalyst and preparation method and application thereof 中国石油化工股份有限公司 2025-04-22 — — CN claimed
US-20240246067-A1 HIGHLY DISPERSED PALLADIUM CATALYSTS JOHNSON MATTHEY DAVY TECHNOLOGIES LIMITED (GB) 2024-07-25 — — US claimed
EP-4334029-A1 HIGHLY DISPERSED PALLADIUM CATALYSTS Johnson Matthey Public Limited Company (GB) 2024-03-13 — — EP claimed
US-11713286-B2 Butadiene telomerization catalyst preparation and use thereof DOW GLOBAL TECHNOLOGIES LLC (US) 2023-08-01 — — US claimed
WO-2023285793-A1 HIGHLY DISPERSED PALLADIUM CATALYSTS JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) 2023-01-19 — — WO claimed
US-20220213006-A1 BUTADIENE TELOMERIZATION CATALYST PREPARATION AND USE THEREOF DOW GLOBAL TECHNOLOGIES LLC (US) 2022-07-07 — — US claimed
CN-107438630-B Butadiene short-chain polymerization catalyst and preparation thereof 陶氏环球技术有限责任公司 2020-09-15 — — CN claimed
CN-109137050-B Graphene-doped modified interconnection belt or bus belt and preparation method thereof 新昌县鸿吉电子科技有限公司 2020-07-17 — — CN claimed
EP-3280690-B1 BUTADIENE TELOMERIZATION CATALYST AND PREPARATION THEREOF DOW GLOBAL TECHNOLOGIES LLC (US) 2019-06-19 — — EP claimed
US-20180072637-A1 BUTADIENE TELOMERIZATION CATALYST AND PREPARATION THEREOF DOW GLOBAL TECHNOLOGIES LLC (US) 2018-03-15 — — US claimed
EP-3280690-A1 BUTADIENE TELOMERIZATION CATALYST AND PREPARATION THEREOF Dow Global Technologies LLC (US) 2018-02-14 — — EP claimed
WO-2016164258-A1 BUTADIENE TELOMERIZATION CATALYST AND PREPARATION THEREOF DOW GLOBAL TECHNOLOGIES LLC (US) 2016-10-13 — — WO claimed
US-20100217052-A1 Catalyst For The Selective Hydrogenation Of Acetylenic Hydrocarbons And Method For Producing Said Catalyst SUD-CHEMIE AG (DE) 2010-08-26 — — US claimed
US-5405583-A Solid state sensor for carbon monoxide FCI - FIBERCHEM, INC. (US) 1995-04-11 — — US claimed
US-5346671-A Redox systems FCI - FIBERCHEM, INC. (US) 1994-09-13 — — US claimed
US-5135900-A Aqueous solution of palladium compound and water soluble phosphine ligand associated with nitrile solvent; catalysts for nucleophilic substitution RHONE-POULENC SANTE (FR) 1992-08-04 — — US claimed
US-4366035-A Electrodeposition of gold alloys ENGELHARD CORPORATION (US) 1982-12-28 — — US claimed
EP-0015909-A1 A METHOD OF PRODUCING THROMBOSIS-RESISTANT SURFACES THIN CONDUCTIVE COATING OSTERMALM (SE) 1980-10-01 — — EP claimed
WO-1979000638-A1 A METHOD OF PRODUCING THROMBOSIS-RESISTANT SURFACES THIN CONDUCTIVE COATING OESTER (SE) 1979-09-06 — — WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11713286-B2 Butadiene telomerization catalyst preparation and use thereof TELO2, TERT, TPR CA4 4334/4885ALDH1A1 954/4885CASP1 4192/4885
US-20180072637-A1 BUTADIENE TELOMERIZATION CATALYST AND PREPARATION THEREOF TELO2, TERT, POT1 CA4 4255/4885ALDH1A1 824/4885CASP1 4355/4885
US-20220213006-A1 BUTADIENE TELOMERIZATION CATALYST PREPARATION AND USE THEREOF TELO2, TERT, TPR CA4 4334/4885ALDH1A1 954/4885CASP1 4192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback